Charlene Banard

Charlene Banard joined the board of directors in March 2022. Ms. Banard is the chief technical officer of Atara Biotherapeutics, Inc. Previously, she served as the global head, of Technical Operations, Cell & Gene Therapy platform of Novartis Pharmaceuticals Corporation. Prior to Novartis, Ms. Banard was senior vice president, Global Quality, Technical Operations at Shire Pharmaceuticals Group PLC, until it was acquired by Takeda Pharmaceutical Company. She also served in multiple leadership positions at Gilead Sciences, Inc., Cell Genesys, Inc., and Chiron Corporation earlier in her career.

Ms. Banard holds a B.S. in biochemistry from University of California at Davis and an M.B.A. in transglobal business from Saint Mary’s College of California in Moraga.